Showing 11 of 11 results
- Control CRISPR screen of PC-3Homo sapiens PC-3 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of DU 145Homo sapiens DU 145 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of NCI-H460Homo sapiens NCI-H460 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of A549Homo sapiens A549 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of MDA-MB-231Homo sapiens MDA-MB-231 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of MCF-7Homo sapiens MCF-7 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of HepG2Homo sapiens HepG2 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of SW620Homo sapiens SW620 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of HCT116Homo sapiens HCT116 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- Control CRISPR screen of K562Homo sapiens K562 genetically modified using CRISPR, transduction 0 days after the sample was treated with 2 μg/mL puromycin for 2 days, 0.2 μg/mL puromycin for 2 daysLab: Bing Ren, UCSDProject: ENCODETreatments: 2 μg/mL puromycin (CHEBI:17939) for 2 days, 0.2 μg/mL puromycin (CHEBI:17939) for 2 days
- pooled clone sequencing of DNA cloning sampleLab: Bing Ren, UCSDProject: ENCODE